Cargando…

The dynamics of plasma biomarkers across the Alzheimer’s continuum

BACKGROUND: Failures in drug trials strengthen the necessity to further determine the neuropathological events during the development of Alzheimer’s disease (AD). We sought to investigate the dynamic changes and performance of plasma biomarkers across the entire Alzheimer’s continuum in the Chinese...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Yu, Shen, Xue-Ning, Wang, Hui-Fu, Chen, Shi-Dong, Zhang, Ya-Ru, Chen, Shu-Fen, Cui, Mei, Cheng, Wei, Dong, Qiang, Ma, Tao, Yu, Jin-Tai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906840/ https://www.ncbi.nlm.nih.gov/pubmed/36750875 http://dx.doi.org/10.1186/s13195-023-01174-0

Ejemplares similares

Head-to-head comparison of 6 plasma biomarkers in early multiple system atrophy
por: Guo, Yu, et al.
Publicado: (2023)

Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status
por: Shen, Xue-Ning, et al.
Publicado: (2021)

Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET
por: Guo, Yu, et al.
Publicado: (2021)

Longitudinal plasma phosphorylated tau 181 tracks disease progression in Alzheimer’s disease
por: Chen, Shi-Dong, et al.
Publicado: (2021)

Plasma amyloid, tau, and neurodegeneration biomarker profiles predict Alzheimer's disease pathology and clinical progression in older adults without dementia
por: Shen, Xue‐Ning, et al.
Publicado: (2020)

Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum
por: Tosun, Duygu, et al.
Publicado: (2021)

Deamidation-related blood biomarkers show promise for early diagnostics of neurodegeneration
por: Wang, Jijing, et al.
Publicado: (2022)

Herpesvirus infections and Alzheimer’s disease: a Mendelian randomization study
por: Huang, Shu-Yi, et al.
Publicado: (2021)

Depressive Symptoms Have Distinct Relationships With Neuroimaging Biomarkers Across the Alzheimer’s Clinical Continuum
por: Moulinet, Inès, et al.
Publicado: (2022)

FDG-PET as an independent biomarker for Alzheimer’s biological diagnosis: a longitudinal study
por: Ou, Ya-Nan, et al.
Publicado: (2019)

Genetically determined low income modifies Alzheimer’s disease risk
por: Wang, Rong-Ze, et al.
Publicado: (2021)

Association of cerebrospinal fluid neurogranin levels with cognition and neurodegeneration in Alzheimer’s disease
por: Xue, Mei, et al.
Publicado: (2020)

Association of serum Apolipoprotein B with cerebrospinal fluid biomarkers of Alzheimer’s pathology
por: Hu, Hao, et al.
Publicado: (2020)

Discordant Alzheimer's neurodegenerative biomarkers and their clinical outcomes
por: Guo, Yu, et al.
Publicado: (2020)

Subtle cognitive impairment as a marker of Alzheimer's pathologies and clinical progression in cognitively normal individuals
por: Shen, Xue‐Ning, et al.
Publicado: (2021)

Clinical and biomarker trajectories in sporadic Alzheimer's disease: A longitudinal study
por: Wang, Hui‐Fu, et al.
Publicado: (2020)

Associations of healthy lifestyles with cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact older adults: the CABLE study
por: Hou, Xiao-He, et al.
Publicado: (2021)

Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer’s disease: a Mendelian randomization study
por: Ou, Ya-Nan, et al.
Publicado: (2021)

Fasting blood glucose and cerebrospinal fluid Alzheimer’s biomarkers in non-diabetic cognitively normal elders: the CABLE study
por: Ou, Ya-Nan, et al.
Publicado: (2020)

Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
por: Benedet, Andréa L., et al.
Publicado: (2021)

Association of Clusterin Levels in Cerebrospinal Fluid with Synaptic Degeneration Across the Alzheimer’s Disease Continuum
por: Wang, Jun, et al.
Publicado: (2020)

Subjective cognitive decline: opposite links to neurodegeneration across the Alzheimer’s continuum
por: Kuhn, Elizabeth, et al.
Publicado: (2021)

Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum
por: Tang, Lian, et al.
Publicado: (2022)

Technical Review of Clinical Outcomes Assessments Across the Continuum of Alzheimer's Disease
por: DiBenedetti, Dana B., et al.
Publicado: (2023)

Plasma p217+tau versus NAV4694 amyloid and MK6240 tau PET across the Alzheimer's continuum
por: Doré, Vincent, et al.
Publicado: (2022)

Multipredictor risk models for predicting individual risk of Alzheimer’s disease
por: Hou, Xiao-He, et al.
Publicado: (2023)

Plasma sex hormone-binding globulin predicts neurodegeneration and clinical progression in prodromal Alzheimer's disease
por: Xu, Wei, et al.
Publicado: (2020)

Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer’s Disease Continuum
por: Chen, Yi-He, et al.
Publicado: (2022)

Grey matter network trajectories across the Alzheimer’s disease continuum and relation to cognition
por: Dicks, Ellen, et al.
Publicado: (2020)

Tau-related grey matter network breakdown across the Alzheimer’s disease continuum
por: Pelkmans, Wiesje, et al.
Publicado: (2021)

Network‐wise concordance of multimodal neuroimaging features across the Alzheimer's disease continuum
por: Stocks, Jane, et al.
Publicado: (2022)

Disentangling tau and brain atrophy cluster heterogeneity across the Alzheimer's disease continuum
por: Toledo, Jon B., et al.
Publicado: (2022)

Dynamic modeling of practice effects across the healthy aging-Alzheimer’s disease continuum
por: Bender, Andrew R., et al.
Publicado: (2022)

Effect of renal function on the diagnostic performance of plasma biomarkers for Alzheimer’s disease
por: Zhang, Bin, et al.
Publicado: (2023)

Plasma biomarker profiles and the correlation with cognitive function across the clinical spectrum of Alzheimer’s disease
por: Xiao, Zhenxu, et al.
Publicado: (2021)

The Relationship Between Muscle Strength and Cognitive Performance Across Alzheimer's Disease Clinical Continuum
por: Filardi, Marco, et al.
Publicado: (2022)

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum
por: Gobom, Johan, et al.
Publicado: (2022)

Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer’s disease continuum
por: Paciotti, Silvia, et al.
Publicado: (2023)

High pulse pressure is a risk factor for prodromal Alzheimer’s disease: a longitudinal study
por: Shi, Wen-Yan, et al.
Publicado: (2020)

Testing extra-linearity across a psychosis continuum
por: Coid, Jeremy W., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dsd98alfltpp77du5kinf487q3